O
ARRY

OppenheimerFunds’s Array Biopharma Inc ARRY Stock Holding History

OppenheimerFunds’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.97M Buy
+327,010
New +$6.81M 0.01% 699

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OppenheimerFunds's ARRY Position: Q1 2019 in Review

OppenheimerFunds opened a new position in Array Biopharma Inc (ARRY) in Q1 2019: 327,010 shares worth $7.97M. The stake represents 0.01% of the portfolio and ranks #699 among its holdings.

268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • OppenheimerFunds held 327,010 shares of Array Biopharma Inc worth $7.97M as of Q1 2019.
  • Array Biopharma Inc was a new OppenheimerFunds position in Q1 2019.
  • Array Biopharma Inc made up 0.01% of OppenheimerFunds's portfolio in Q1 2019, its #699 holding.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.